Preoperative detection of functional somatostatin receptors in a patient with an insulinoma.

Kohei Oguni Shinnosuke FukushimaYukichika YamamotoKou HasegawaHideharu HagiyaNaoko InoshitaFumio Otuska

Published in: Clinical case reports (2023)

Octreotide is used in patients with insulinomas to treat hypoglycemia, and somatostatin receptor (SSTR) 2 expression is important for its efficacy. We report a case of insulinoma in a 50-year-old woman that responded to an octreotide test, showed accumulation in somatostatin scintigraphy, and was positive for SSTR2A on immunostaining.

Keyphrases

neuroendocrine tumors
poor prognosis
type diabetes
case report
patients undergoing
binding protein
metabolic syndrome
weight loss